診断薬受託製造市場：タイプ、サービス、用途別-2025-2030年の世界予測

診断薬受託製造市場の2023年の市場規模は286億3,000万米ドルで、2024年には314億9,000万米ドルに達すると予測され、CAGR 10.37％で成長し、2030年には571億4,000万米ドルに達すると予測されています。

診断薬受託製造は、診断薬の開発と生産を専門の第三者メーカーにアウトソーシングすることを意味します。このセクターは主に医療診断に対応し、試薬、アッセイ、分析機器などの必須コンポーネントを生産しています。診断薬受託製造の必要性は、費用対効果の高いソリューションへの需要の高まり、合理化された生産の必要性、高額な設備投資をすることなく急速に事業を拡大する能力に起因しています。用途は遺伝子検査、感染症診断、個別化医療など多岐にわたり、病院、診療所、研究所などのエンドユーザーにサービスを提供しています。

市場成長は、ヘルスケア支出の増加、診断における自動化やAIなどの技術進歩、高度な診断を必要とする慢性疾患や感染症の増加による影響が大きいです。さらに、COVID-19のパンデミックは堅牢な診断ソリューションへの需要を加速させ、受託製造の必要性をさらに強調しました。主なビジネスチャンスは、分子診断と個別化医療ソリューションの提供の多様化、および疾患の有病率は高いが診断能力が低い新興市場へのサービス拡大にあります。企業はバイオテクノロジー企業やヘルスケアプロバイダーとの提携に投資し、製品ポートフォリオと市場リーチを強化すべきです。

しかし、市場は厳しい規制要件、高い競合、知的財産に関する守秘義務などの課題に直面しています。また、対象市場における経済的制約も制限要因となり得る。こうしたハードルを克服するためには、デジタルヘルス診断と遠隔医療アプリケーションのイノベーションに注力することが変革をもたらす可能性があります。小型化された診断機器の研究開発に投資し、IoT対応ソリューションを統合することで、企業はコスト意識の高い層や技術に精通した層にアピールすることができます。市場は競争的でありながらイノベーションの機は熟しており、ダイナミックな情勢は、急成長する機会を捉え、課題に効果的に対処するための敏捷性と戦略的パートナーシップを要求しています。

市場力学：急速に進化する診断薬受託製造市場の主要市場インサイトを公開

診断薬受託製造市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 診断企業による、費用対効果が高く最適化されたプロセスへの高い要求
  • 予防医療への意識の高まりと診断検査の採用拡大
• 市場抑制要因
  • 製造施設設立に伴う高コスト
• 市場機会
  • 診断薬製造プロセスにおける技術進歩
  • 受託製造における持続可能でグリーンな手法の開発
• 市場の課題
  • 製品の品質と知的財産権の確保に伴うリスク

ポーターのファイブフォース診断薬受託製造市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：診断薬受託製造市場における外部からの影響の把握

外部マクロ環境要因は、診断薬受託製造市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析診断薬受託製造市場における競合情勢の把握

診断薬受託製造市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス診断薬受託製造市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、診断薬受託製造市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨診断薬受託製造市場における成功への道筋を描く

診断薬受託製造市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 診断会社によるコスト効率の高い最適化されたプロセスに対する高い需要
    • 予防ヘルスケアへの意識の高まりと診断検査の導入の増加
  • 抑制要因
    • 製造施設の設置にかかるコストが高い
  • 機会
    • 診断製造プロセスにおける技術的進歩
    • 契約製造における持続可能かつ環境に優しい実践の開発
  • 課題
    • 製品の品質と知的財産権の確保に伴うリスク
• 市場セグメンテーション分析
  • タイプ：最小限の投資で新規市場への参入や既存製品ラインの増強を目的としたプライベートラベル製造サービスの需要が高まっています。
  • アプリケーション：診断用画像装置向け診断薬受託製造サービスの採用増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 診断薬受託製造市場：タイプ別

• エンドツーエンドの製造
• 個別部品製造
• 労働またはサービスの下請け
• プライベートラベル製造

第7章 診断薬受託製造市場：サービス別

• 梱包および組立サービス
• 製品開発および製造サービス
• 品質管理サービス

第8章 診断薬受託製造市場：用途別

• 画像診断装置
• 処方開発
• 体外診断装置

第9章 南北アメリカの診断薬受託製造市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の診断薬受託製造市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの診断薬受託製造市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • 富士レビオとアガッペの戦略的業務提携により診断ソリューションが強化
  • Axim Biotechnologies、Auer Precisionとの提携を通じてアッセイ生産を強化
  • 診断製造の卓越性への戦略的投資によるアルマックグループの拡大
• 戦略分析と提言

企業一覧

• Argonaut Manufacturing Services Inc.
• Bio-Techne Corporation
• Celestica Inc.
• Comar
• Donatelle
• EKF Diagnostics Holdings PLC
• FlexMedical Solutions
• Fortis Life Sciences
• Gerresheimer AG
• Invetech
• Invetech Pty. Ltd.
• Jabil Inc.
• Keller Technology Corporation
• KMC Systems by Elbit Systems Ltd.
• LaunchWorks CDMO
• Merck KGaA
• Microcoat Biotechnologie GmbH
• Prestige Diagnostics
• Sanmina Corporation
• Savyon Diagnostics
• SCHOTT AG
• TCS Biosciences
• TE Connectivity Ltd.
• TECHLAB, Inc.
• Thermo Fisher Scientific Inc.

LIST OF FIGURES

• FIGURE 1. DIAGNOSTIC CONTRACT MANUFACTURING MARKET RESEARCH PROCESS
• FIGURE 2. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. DIAGNOSTIC CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. DIAGNOSTIC CONTRACT MANUFACTURING MARKET DYNAMICS
• TABLE 7. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY END-TO-END MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY INDIVIDUAL COMPONENT MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY LABOR OR SERVICE SUBCONTRACTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PRIVATE LABEL MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PACKAGING & ASSEMBLY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY PRODUCT DEVELOPMENT & MANUFACTURING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY QUALITY MANAGEMENT SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY DIAGNOSTIC IMAGING DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY IN VITRO DIAGNOSTIC DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 32. CANADA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 49. CHINA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 52. INDIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 104. ITALY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 116. POLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 119. QATAR DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM DIAGNOSTIC CONTRACT MANUFACTURING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. DIAGNOSTIC CONTRACT MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. DIAGNOSTIC CONTRACT MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2023

The Diagnostic Contract Manufacturing Market was valued at USD 28.63 billion in 2023, expected to reach USD 31.49 billion in 2024, and is projected to grow at a CAGR of 10.37%, to USD 57.14 billion by 2030.

Diagnostic Contract Manufacturing encompasses the outsourcing of diagnostic product development and production to specialized third-party manufacturers. This sector caters primarily to medical diagnostics, producing essential components like reagents, assays, and analytical instruments. The necessity for diagnostic contract manufacturing stems from the growing demand for cost-effective solutions, the need for streamlined production, and the capability to scale operations rapidly without hefty capital investments. Applications range widely, including genetic testing, infectious disease diagnostics, and personalized medicine, serving end-users such as hospitals, clinics, and laboratories.

The market growth is largely influenced by increasing healthcare expenditure, technological advancements such as automation and AI in diagnostics, and the rise in chronic and infectious diseases necessitating advanced diagnostics. Furthermore, the COVID-19 pandemic accelerated demand for robust diagnostic solutions, further emphasizing the need for contract manufacturing. Key opportunities lie in diversifying offerings in molecular diagnostics and personalized medical solutions, as well as expanding services into emerging markets with a high prevalence of diseases but lower diagnostic capabilities. Companies should invest in partnerships with biotech firms and healthcare providers to enhance product portfolio and market reach.

However, the market faces challenges including stringent regulatory requirements, high competition, and confidentiality concerns regarding intellectual property. Economic constraints in target markets can also be a limiting factor. To overcome these hurdles, focusing on innovations in digital health diagnostics and telemedicine applications could be transformative. By investing in R&D for miniaturized diagnostic devices and integrating IoT-enabled solutions, companies can appeal to the cost-conscious and technologically savvy segments. The market is competitive, yet ripe for innovation, with a dynamic landscape demanding agility and strategic partnerships to capture burgeoning opportunities and address the challenges effectively.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diagnostic Contract Manufacturing Market

The Diagnostic Contract Manufacturing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • High demand for cost-effective and optimized processes by diagnostic companies
  • Increasing awareness of preventive healthcare and growing adoption of diagnostic tests
• Market Restraints
  • High cost associated with setting up manufacturing facility
• Market Opportunities
  • Technological advancement in diagnostic manufacturing processes
  • Development of sustainable and green practices in contract manufacturing
• Market Challenges
  • Risk associated with ensuring product quality and intellectual property rights

Porter's Five Forces: A Strategic Tool for Navigating the Diagnostic Contract Manufacturing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diagnostic Contract Manufacturing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diagnostic Contract Manufacturing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diagnostic Contract Manufacturing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diagnostic Contract Manufacturing Market

A detailed market share analysis in the Diagnostic Contract Manufacturing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diagnostic Contract Manufacturing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diagnostic Contract Manufacturing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diagnostic Contract Manufacturing Market

A strategic analysis of the Diagnostic Contract Manufacturing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diagnostic Contract Manufacturing Market, highlighting leading vendors and their innovative profiles. These include Argonaut Manufacturing Services Inc., Bio-Techne Corporation, Celestica Inc., Comar, Donatelle, EKF Diagnostics Holdings PLC, FlexMedical Solutions, Fortis Life Sciences, Gerresheimer AG, Invetech, Invetech Pty. Ltd., Jabil Inc., Keller Technology Corporation, KMC Systems by Elbit Systems Ltd., LaunchWorks CDMO, Merck KGaA, Microcoat Biotechnologie GmbH, Prestige Diagnostics, Sanmina Corporation, Savyon Diagnostics, SCHOTT AG, TCS Biosciences, TE Connectivity Ltd., TECHLAB, Inc., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Diagnostic Contract Manufacturing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across End-to-End Manufacturing, Individual Component Manufacturing, Labor or Service Subcontracting, and Private Label Manufacturing.
• Based on Services, market is studied across Packaging & Assembly Services, Product Development & Manufacturing Services, and Quality Management Services.
• Based on Application, market is studied across Diagnostic Imaging Devices, Formulation Development, and In Vitro Diagnostic Devices.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. High demand for cost-effective and optimized processes by diagnostic companies
    • 5.1.1.2. Increasing awareness of preventive healthcare and growing adoption of diagnostic tests
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with setting up manufacturing facility
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancement in diagnostic manufacturing processes
    • 5.1.3.2. Development of sustainable and green practices in contract manufacturing
  • 5.1.4. Challenges
    • 5.1.4.1. Risk associated with ensuring product quality and intellectual property rights
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing demand for private label manufacturing services aimed at entering new markets or augmenting existing product lines with minimal investment
  • 5.2.2. Application: Rising adoption of diagnostic contract manufacturing services for diagnostic imaging devices
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Diagnostic Contract Manufacturing Market, by Type

• 6.1. Introduction
• 6.2. End-to-End Manufacturing
• 6.3. Individual Component Manufacturing
• 6.4. Labor or Service Subcontracting
• 6.5. Private Label Manufacturing

7. Diagnostic Contract Manufacturing Market, by Services

• 7.1. Introduction
• 7.2. Packaging & Assembly Services
• 7.3. Product Development & Manufacturing Services
• 7.4. Quality Management Services

8. Diagnostic Contract Manufacturing Market, by Application

• 8.1. Introduction
• 8.2. Diagnostic Imaging Devices
• 8.3. Formulation Development
• 8.4. In Vitro Diagnostic Devices

9. Americas Diagnostic Contract Manufacturing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Diagnostic Contract Manufacturing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Diagnostic Contract Manufacturing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Strategic Business Collaboration Between Fujirebio and Agappe Enhances Diagnostic Solutions
  • 12.3.2. Axim Biotechnologies Boosts Assay Production Through Auer Precision Partnership
  • 12.3.3. Expansion of Almac Group Through a Strategic Investment in Diagnostic Manufacturing Excellence
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Argonaut Manufacturing Services Inc.
• 2. Bio-Techne Corporation
• 3. Celestica Inc.
• 4. Comar
• 5. Donatelle
• 6. EKF Diagnostics Holdings PLC
• 7. FlexMedical Solutions
• 8. Fortis Life Sciences
• 9. Gerresheimer AG
• 10. Invetech
• 11. Invetech Pty. Ltd.
• 12. Jabil Inc.
• 13. Keller Technology Corporation
• 14. KMC Systems by Elbit Systems Ltd.
• 15. LaunchWorks CDMO
• 16. Merck KGaA
• 17. Microcoat Biotechnologie GmbH
• 18. Prestige Diagnostics
• 19. Sanmina Corporation
• 20. Savyon Diagnostics
• 21. SCHOTT AG
• 22. TCS Biosciences
• 23. TE Connectivity Ltd.
• 24. TECHLAB, Inc.
• 25. Thermo Fisher Scientific Inc.